July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Engineering pectin-polyhydroxybutyrate nanofibers as scaffolds for retinal pigment epithelial cell-based therapeutics
Author Affiliations & Notes
  • Bhav Harshad Parikh
    Ophthalmology, National University of Singapore, Singapore, Singapore
  • Siew Yin Chan
    Institute of Materials Research and Engineering, Singapore, Singapore
  • Dan Kai
    Institute of Materials Research and Engineering, Singapore, Singapore
  • Xinyi Su
    Ophthalmology, National University of Singapore, Singapore, Singapore
    Institute of Molecular and Cell Biology, Singapore, Singapore
  • Xian Jun Loh
    Institute of Materials Research and Engineering, Singapore, Singapore
    Materials Science and Engineering, National University of Singapore, Singapore, Singapore
  • Zengping Liu
    Ophthalmology, National University of Singapore, Singapore, Singapore
  • Footnotes
    Commercial Relationships   Bhav Parikh, None; Siew Yin Chan, None; Dan Kai, None; Xinyi Su, None; Xian Jun Loh, None; Zengping Liu, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5003. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Bhav Harshad Parikh, Siew Yin Chan, Dan Kai, Xinyi Su, Xian Jun Loh, Zengping Liu; Engineering pectin-polyhydroxybutyrate nanofibers as scaffolds for retinal pigment epithelial cell-based therapeutics
      . Invest. Ophthalmol. Vis. Sci. 2018;59(9):5003.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Recent reports have proposed the possibility of seeding retinal pigment epithelial (RPE) cells onto soft, polymeric scaffolds. Achieving good viabilities, differentiation and integration of RPE cells remains a challenge. Furthermore, there are no ideal biocompatible scaffolds for RPE transplantation to date. Therefore, the aim of this work is evaluate the potential of pectin-polyhydroxybutyrate (pec-PHB) nanofibers as scaffolds for RPE cell therapeutics in terms of their topography, thermal and mechanical properties.

Methods : Pec-PHB mixtures of five different ratios of pectin to PHB were obtained by electrospinning. The mean fibre diameter ranges from 300 to 500 nm. Commercially available human RPE cell line (ARPE-19) was used for all the in vitro experiments. Cells were seeded at 1.00 ×104 cells cm-2 onto five different blends of pec-PHB nanofibers and coverslips served as positive control. Cell viability and proliferation were tested using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay at days 1, 3 and 7 post-seeding. Immunofluorescence was performed using rhodamine phalloidin to certify the growth and distribution of cells 24 hours post-seeding. The morphology and attachment of the cells were observed by scanning electron microscopy (SEM).

Results : Quantification of cell proliferation using MTT assay revealed higher cell densities on pec-PHB10 and pec-PHB20 as compared to the other three groups seven days after seeding (one-way ANOVA, p < 0.05). The presence and distribution of F-actin on all groups was consistent with the pattern of expression observed on positive control. SEM analysis of cell morphology exhibited rounded and localized cells on pec-PHB10 and pec-PHB20 nanofibers, characteristic of RPE cells, as seen on positive controls. This morphology was however not retained in the other groups.

Conclusions : ARPE-19 cells successfully adhered to all groups of pec-PHB nanofibers within 24 hours of seeding and were able to proliferate showing short-term biocompatibility. Pec-PHB10 and pec-PHB20 groups demonstrated superiority in providing favourable features for RPE cell growth. Continued research should thus be concentrated on these two blends to study the differentiation, long-term biocompatibility and subsequently integration.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×